Astellas, Amgen To Pay $125M To End Kickback Probe
Astellas Pharma US Inc. and Amgen Inc. will pay a combined $125 million to settle allegations that they used charities to subsidize Medicare co-pays for their own drugs in what amounted...To view the full article, register now.
Already a subscriber? Click here to view full article